 TORONTO, ON ACCESSWIRE June 8, 2021 Edesa Biotech, Inc. NASDAQ:EDSA, a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that the companys senior management are scheduled to attend the 2021 BIO Digital Conference being held June 14-18, 2021. Members of the biopharma or investment community who are interested in meeting with Edesa during the conference may contact the company on the BIO One-on-One Partnering system, or at 